ES8303400A1 - "procedimiento para preparar derivados de bencilazol." - Google Patents

"procedimiento para preparar derivados de bencilazol."

Info

Publication number
ES8303400A1
ES8303400A1 ES512151A ES512151A ES8303400A1 ES 8303400 A1 ES8303400 A1 ES 8303400A1 ES 512151 A ES512151 A ES 512151A ES 512151 A ES512151 A ES 512151A ES 8303400 A1 ES8303400 A1 ES 8303400A1
Authority
ES
Spain
Prior art keywords
benzylazole
derivatives
epoxypropyloxybenzylazole
chem
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512151A
Other languages
English (en)
Other versions
ES512151A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES512151A0 publication Critical patent/ES512151A0/es
Publication of ES8303400A1 publication Critical patent/ES8303400A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE BENCILAZOL Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE A, B, X, Y, Z, R Y R PUEDEN SER VARIOS RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R NHR , EN LAS QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN PRESENCIA O AUSENCIA DE UN DISOLVENTE INERTE, A UNA TEMPERATURA ENTRE 25 C Y 100 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIARRITMICOS.
ES512151A 1981-05-14 1982-05-13 "procedimiento para preparar derivados de bencilazol." Expired ES8303400A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56072986A JPS57188570A (en) 1981-05-14 1981-05-14 Benzylazole derivative

Publications (2)

Publication Number Publication Date
ES512151A0 ES512151A0 (es) 1983-02-01
ES8303400A1 true ES8303400A1 (es) 1983-02-01

Family

ID=13505217

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512151A Expired ES8303400A1 (es) 1981-05-14 1982-05-13 "procedimiento para preparar derivados de bencilazol."

Country Status (16)

Country Link
US (1) US4430331A (es)
EP (1) EP0066144B1 (es)
JP (1) JPS57188570A (es)
KR (1) KR860001580B1 (es)
AU (1) AU554243B2 (es)
CA (1) CA1193255A (es)
DE (2) DE3269141D1 (es)
DK (1) DK161317C (es)
ES (1) ES8303400A1 (es)
GB (1) GB2103600B (es)
HU (1) HU188059B (es)
IE (1) IE52989B1 (es)
IL (1) IL65735A (es)
NZ (1) NZ200471A (es)
PH (1) PH17989A (es)
ZA (1) ZA823207B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343671A1 (de) * 1983-12-02 1985-06-20 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von substituierten 2-hydroxy-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870726A (en) 1970-09-09 1975-03-11 Bayer Ag Derivatives of 3-azolylpropyne and processes for their preparation and use
CH584695A5 (en) * 1973-02-20 1977-02-15 Ciba Geigy Ag 3-amino-2-hydroxypropoxy substd. diazines and pyridines - with beta-adrenergic blocking or stimulating activity
SE7601713L (sv) * 1975-03-03 1976-09-06 Merck & Co Inc Nya, substituerad imidazoler
CA1111433A (en) * 1977-10-19 1981-10-27 Peter B. Thorogood Imidazole derivatives and their salts
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
GB2041363B (en) * 1979-01-19 1982-10-06 Pfizer Ltd N-benzyl-imidazoles
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives

Also Published As

Publication number Publication date
IL65735A (en) 1986-04-29
EP0066144A2 (en) 1982-12-08
NZ200471A (en) 1985-08-30
GB2103600B (en) 1985-01-09
ES512151A0 (es) 1983-02-01
JPS6325583B2 (es) 1988-05-26
CA1193255A (en) 1985-09-10
PH17989A (en) 1985-02-28
DK161317C (da) 1991-12-30
ZA823207B (en) 1983-03-30
KR830010079A (ko) 1983-12-26
JPS57188570A (en) 1982-11-19
IL65735A0 (en) 1982-08-31
AU8318082A (en) 1982-11-18
DE66144T1 (de) 1983-05-26
DE3269141D1 (de) 1986-03-27
GB2103600A (en) 1983-02-23
EP0066144A3 (en) 1983-11-30
AU554243B2 (en) 1986-08-14
DK216282A (da) 1982-11-15
HU188059B (en) 1986-03-28
US4430331A (en) 1984-02-07
KR860001580B1 (ko) 1986-10-10
DK161317B (da) 1991-06-24
IE821134L (en) 1982-11-14
IE52989B1 (en) 1988-04-27
EP0066144B1 (en) 1986-02-19

Similar Documents

Publication Publication Date Title
IL74223A0 (en) Carbamate compounds,compositions,and methods of making the same
ES8700672A1 (es) Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos.
GR851145B (es)
GR77338B (es)
ATE31414T1 (de) 8-substituierte pyrrolizidin-derivate und deren verwendung.
ATE50773T1 (de) Alkylresorcinolphosphite.
IL62332A (en) Antimycotic compositions comprising 1,1-diphenyl-2-(1,2,4-triazol-1-yl)-ethan-1-ols,a certain such compound and its preparation
ES8505994A1 (es) Un metodo para preparar 2(1h)-piridinonas
ES8701737A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES8303400A1 (es) "procedimiento para preparar derivados de bencilazol."
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
EG17841A (en) New-benzotriazoles the preparation thereof and their use as fungicides
ES8406156A1 (es) Procedimiento para la preparacion de n-pteridinil-ureas(como divisional de la patente numero 521.331)
ES8708132A1 (es) Procedimiento para preparar n-fenil-4-fenil-1-piperazincarboxamidinas y compuestos afines como agentes anti-arritmicos
ES479627A1 (es) Un procedimiento para la preparacion de 1,4-bis-piperonilpi-peracina y similares.
ES2014041A6 (es) Un procedimiento para preparar un derivado de amina.
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
GB1467942A (en) Amine condensate
ES532852A1 (es) Procedimiento para la obtencion de alquilen-bis-heterociclilbiguanidas
ES8702877A1 (es) Un metodo para producir un derivado de acido benzoico.
ES8503659A1 (es) "un procedimiento para preparar nuevos derivados de aminobenzamida"
ES8504714A1 (es) Procedimiento para preparar 1-(fenilcarbamoiloxi)-2-butino con propiedades herbicidas.
ES8302712A1 (es) Un nuevo procedimiento de preparacion de imidazobenzodiazepinas.
ES8602645A1 (es) Procedimiento para la obtencion de derivados del acido feno-xipropionico substituidos
UA5806A1 (uk) Похідні заміщеного 2-алкілті0-4,5-диметил-3-етилтіазолію як проміжний продукт для синтезу нульметинмероціанинових барвинків, спосіб їх одержання та спосіб одержання барвників на їх основі

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001